John F. Thompson

The paper introduces a method to handle omics data variation across platforms and times, showing its use in three disease risk models for clinical application.

This paper develops a gene expression signature, Cam_121, to predict long-term outcomes in primary melanoma patients, showing improved accuracy compared to clinical and existing prognostic models.